Data from the federal government shows that Mississippi consistently ranks in the top five in the nation for its rates of ...

The FDA is poised to issue a decision soon on KarXT, a potential first-in-class antipsychotic for schizophrenia. What should ...

A new nationwide Danish study published in The Lancet Psychiatry found that individuals with schizophrenia spectrum disorders ...

The use of antipsychotics for schizophrenia was associated with higher risk for severe cases of COVID-19 and non–COVID-19 respiratory infections but not mild infection.

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), announced new positive efficacy, safety and ...

The following is a summary of “Antipsychotic exposure and infection risk in people with schizophrenia spectrum disorders ...

But the healthcare system in the US still struggles to provide adequate care for those with serious mental illness ...

Pharmacological therapy plays a vital role in treating this disease, where many mono and combination pharmacological ...

A new study in the peer-reviewed Journal of Child and Adolescent Psychopharmacology estimated the incidence of neuroleptic malignant syndrome (NMS), a potentially fatal adverse effect of antipsychotic ...

Credit: Nathan Griffith/Getty Images Federal policies designed to reduce use of antipsychotic medications in nursing homes did not lead to clinically significantly higher rates of schizophrenia ...

“They just gave me pills and said, here, take them,” he said.